532296:BOM
Glenmark Pharmaceuticals Ltd
₹2,239.80
arrow_downward
-0.47%(-10.50) 1D
Oct 16, 12:48:22 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹2,249.80
High
₹2,264.00
Low
₹2,232.50
Mkt. cap
632.47B
Avg. vol.
17.97K
Volume
7.00K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.17
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,249.80
High
₹2,264.00
Low
₹2,232.50
Mkt. cap
632.47B
Avg. vol.
17.97K
Volume
7.00K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.17
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
Moomoo
·
22 minutes ago
Dow Jones Top Company Headlines at 3 AM ET: Tesla's New Roadster Takes Flight After Nearly a Decade of Delays | Schneider ...
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga
·
46 minutes ago
Dow Jumps Over 550 Points Following Economic Data: Investor Sentiment Improves, But Fear & Greed Index Re
The Motley Fool
·
4 hours ago
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd